01.06.2013 Views

7° Congresso Nazionale

7° Congresso Nazionale

7° Congresso Nazionale

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>7°</strong> <strong>Congresso</strong> <strong>Nazionale</strong> Associazione Italiana di Endourologia<br />

Minimally invasive treatments for LUTS related to BPH:<br />

an update.<br />

Summary<br />

D. Prezioso, R. Galasso, G. Iapicca, E. Annunziata, F. Iacono<br />

Department of Urology, “Federico II” University of Naples<br />

Objective: The aim of our review is to provide updated information regarding the role<br />

of minimally invasive endourological techniques to treat lower urinary tract symptoms<br />

(LUTS) due to benign prostatic hyperplasia (BPH). We reviewed the literature and the<br />

BPH guidelines, focusing the attenction on randomized controlled trials with significant<br />

number of patients and long-term follow up series. We have considered a large<br />

number of parameters related to minimally invasive interventions, such as the short- and longterm<br />

outcome, complications, morbidity, need for anaesthesia, also comparing the current data<br />

regarding the trans-urethral resection of prostate (TURP).<br />

Results: The minimally invasive therapies can be divided into: thermal-based tehrapies, laser<br />

therapies, ablative therapies and other technologies. They represent a good alternative to<br />

TURP, with interesting results regarding their efficacy and tolerability. The most attractive<br />

treatments are high-energy trans-urethral microwave thermotherapy (TUMT), holmium-laser<br />

resection/enucleation (HoLRP/HoLEP), bipolar trans-urethral resection in saline (TURIS) and<br />

transurethral electrovaporization (TUVP). However, also other new interventions show a good<br />

safety profile and low economical costs.<br />

Conclusions: Today, minimally invasive treatments are a good alternative to traditional TURP,<br />

but prospective, long-term randomized trials are need to evaluate the real outcome.<br />

KEY WORDS: Minimally invasive treatments; Trans-urethral microwave thermotherapy;<br />

Holmium-laser resection/enucleation; Bipolar trans-urethral resection in saline;<br />

Transurethral electrovaporization, Trans-urethral needle ablation.<br />

INTRODUCTION<br />

For a long period of time, transurethral resection of the<br />

prostate (TURP) was considered the “gold standard” surgical<br />

therapy for patients with LUTS related to BPH (1),<br />

associated with significant efficacy (2), but also with<br />

severe morbidity (3-6).<br />

New surgical and minimally invasive treatments show a<br />

comparable efficacy to TURP, with better safety and<br />

lower costs, in terms of quality of life and time of hospitalization.<br />

Aim of this review is to provide updated information<br />

about the role of minimally invasive therapies, analyzing<br />

the evidence-based data of randomized clinical trials and<br />

the recommendations of BPH guidelines (7,8). We<br />

reviewed the literature and the BPH guidelines, focusing<br />

the attenction on randomized controlled trials with significant<br />

number of patients and long-term follow up<br />

series. We have considered a large number of parameters<br />

related to minimally invasive interventions, such as the<br />

short- and long-term outcome, complications, morbidity,<br />

need for anaesthesia, also comparing the current data<br />

regarding the trans-urethral resection of prostate<br />

(TURP).<br />

TRANS-URETHRAL MICROWAVE THERMOTHERAPY (TUMT)<br />

Thermotherapy uses high temperatures to produce coagulation<br />

necrosis of prostatic tissue. Microwaves delivered<br />

via the transurethral route have been the dominant<br />

means used to heat prostatic tissue. TUMT uses a special<br />

transurethral catheter with a microwave antenna that<br />

transmits heat into the prostate with the eventual goal of<br />

destroying tissue by achieving temperatures that exceed<br />

the cytotoxic threshold and inducing cell death. More<br />

specifically, heating in excess of 45°C results in coagulation<br />

necrosis. In addition, apoptosis has been observed,<br />

at temperatures lower than those inducing necrosis.<br />

Recently, it was demonstrated that TUMT increased the<br />

sensory threshold (evoked by electrical stimulation) in<br />

the posterior urethra by 30%, resulting in the alleviation<br />

of storage symptoms (9). During the last decade, numerous<br />

studies have been published presenting the clinical<br />

results from the application of TUMT for the treatment of<br />

LUTS associated with BPH. Many TUMT devices with<br />

different technical specifications and treatment protocols<br />

have been evaluated. Bolmsjo et al (10) reported substantial<br />

differences in heating profiles between devices<br />

with different microwave antenna designs. However, at<br />

Archivio Italiano di Urologia e Andrologia 2007, 79, 3, Supplemento 1<br />

47

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!